Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Prothrombin Complex Concentrates (PCCs) Have Limited Effect on TF-Initiated Thrombin Generation in FXa Inhibitor-Anticoagulated Plasma: In Vitro Comparison between Direct Reversal By Andexanet Alfa and "Work Around" By PCCs

Genmin Lu, Joyce P. Lin, BS, Khanh Bui, BS, John T. Curnutte, MD PhD, Pamela B. Conley, PhD

Blood (2019) 134 (Supplement_1): 713.

https://doi.org/10.1182/blood-2019-124864

Published: 2019

Journal Articles

A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Marisol Betensky, MDMPH, Ernest Amankwah, PhD, Stephanie Brandal, Allen Everett, MD, Neil A Goldenberg, MD PhD

Blood (2019) 134 (Supplement_1): 2424.

https://doi.org/10.1182/blood-2019-131821

Published: 2019

Journal Articles

A Novel Laboratory Assay for Monitoring Unfractionated Heparin in Patients Taking Direct Oral Anticoagulants Prior to Hospital Admission

Sydney Strickland, PhD BS, Surabhi Palkimas, PharmD, Julianne Fallon, MD, Thomas Schultz, PharmD, Rebecca Hockman, Mary Acker, Lindsay Bazydlo, PhD

Blood (2017) 130 (Supplement 1): 3721.

https://doi.org/10.1182/blood.V130.Suppl_1.3721.3721

Published: 2017

Journal Articles

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Debbie Jiang, MD, Anne Dumont, RN, Adrienne J. Burns, MMS, PA-C, Henry Rinder, MD, Christopher A. Tormey, MD, Alfred Lee, MD PhD

Blood (2017) 130 (Supplement 1): 3741.

https://doi.org/10.1182/blood.V130.Suppl_1.3741.3741

Published: 2017

Journal Articles

Rebound Hypercoagulability Following a Conventional Course of Anticoagulation and the Risk of Recurrent Venous Thromboembolism in Young Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Marisol Betensky, MDMPH, Gail Mueller, MT, Ernest Amankwah, PhD, Neil A Goldenberg, MD PhD

Blood (2017) 130 (Supplement 1): 556.

https://doi.org/10.1182/blood.V130.Suppl_1.556.556

Published: 2017

Journal Articles

Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid Syndrome

Natalie H Wallace, MD MPH, Anne Dumont, BS, Adrienne Burns, PA, Tormey A Christopher, MD, Henry M Rinder, MD, Martin A Kriegel, MD PhD, Lenore M Buckley, MD MPH, Doruk Erkan, MD MPH, Alfred I Lee, MD PhD

Blood (2016) 128 (22): 4983.

https://doi.org/10.1182/blood.V128.22.4983.4983

Published: 2016

Journal Articles

Multiple Myeloma Cells Adhere to Netrin-1 Via Heparin-Sulphate Moieties

Jeesun Park, B.A., David R Fooksman, Ph.D., Amitabha Mazumder, M.D., Michael L Dustin, Ph.D

Blood (2012) 120 (21): 3952.

https://doi.org/10.1182/blood.V120.21.3952.3952

Published: 2012

Journal Articles

Product Associated Variation in Generic Enoxaparin. Potential Clinical Implications

Jawed Fareed, PhD, Debra Hoppensteadt, Ph.D., Albara Ottman, Omer Iqbal, MD, Walter Jeske, Ph.D., Angel Gray, Jeanine M. Walenga, PhD, Evi Kalodiki, PhD, Indermohan Thethi, MD, Rakesh Wahi, MD

Blood (2011) 118 (21): 1249.

https://doi.org/10.1182/blood.V118.21.1249.1249

Published: 2011

Journal Articles

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Jawed Fareed, PhD, Rakesh Wahi, MD, Indermohan Thethi, MD, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD, Jeanine M. Walenga, PhD, Harry L. Messmore, MD

Blood (2011) 118 (21): 4322.

https://doi.org/10.1182/blood.V118.21.4322.4322

Published: 2011

Journal Articles

Comparative Studies on An Anti-Xa Enriched Ultra Low Molecular Weight Heparin with Bemiparin

Debra Hoppensteadt, Ph.D., Angel Gray, Josephine Cunanan, MD, Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, PhD

Blood (2010) 116 (21): 4394.

https://doi.org/10.1182/blood.V116.21.4394.4394

Published: 2010

Journal Articles

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

Jawed Fareed, Eduardo Ramacciotti, Debra Hoppensteadt, Nasir Sadeghi, Arif Hussain, David VanThiel, Magdalena George

Blood (2009) 114 (22): 1070.

https://doi.org/10.1182/blood.V114.22.1070.1070

Published: 2009

Journal Articles

HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium

Chiara Urbinati, Stefania Nicoli, Mauro Giacca, Guido David, Simona Fiorentini, Arnaldo Caruso, Massimo Alfano, Luca Cassetta, Marco Presta, Marco Rusnati

Blood (2009) 114 (15): 3335–3342.

https://doi.org/10.1182/blood-2009-01-198945

Published: 2009

Includes: Supplemental data

Journal Articles

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Cafer Adiguzel, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD

Blood (2008) 112 (11): 4048.

https://doi.org/10.1182/blood.V112.11.4048.4048

Published: 2008

Journal Articles

Recombinant Factor VIIa Combined with Fibrinogen Corrects the Coagulopathy Associated with Cardiopulmonary Bypass Surgery Ex Vivo

Pall T. Onundarson, M.D., Hanna S. Asvaldsdottir, M.Sc., Brynja R. Gudmundsdottir, M.Sc., Benny Sorensen, M.D., Ph.D.

Blood (2008) 112 (11): 4097.

https://doi.org/10.1182/blood.V112.11.4097.4097

Published: 2008

Journal Articles

Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.

Michael L Schmitz, MD, Edgar D St. Amour, M.Sc., Kimo Stine, MD, Mark A Austen, MS, Chanhee Jo, PhD, Pamela Killebrew, RNP, Robert J Jaquiss, MD

Blood (2008) 112 (11): 1225.

https://doi.org/10.1182/blood.V112.11.1225.1225

Published: 2008

Journal Articles

Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.

Walter P. Jeske, PhD, Aleah Brubaker, B.S., Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, Ph.D., Qing Ma, Ph.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3999.

https://doi.org/10.1182/blood.V110.11.3999.3999

Published: 2007

Journal Articles

Glycosaminoglycans as Anticoagulants in Mucopolysaccharidosis Type I (MPS I).

Jakub Tolar, MD, PhD, Paul J. Orchard, M.D., Nigel Key, M.D., Bruce R. Blazar, M.D.

Blood (2007) 110 (11): 3951.

https://doi.org/10.1182/blood.V110.11.3951.3951

Published: 2007

Journal Articles

Glycosaminoglycans as Anticoagulants in Mucopolysaccharidosis Type I (MPS I).

Jakub Tolar, MD, PhD, Paul J. Orchard, M.D., Nigel Key, M.D., Bruce R. Blazar, M.D.

Blood (2007) 110 (11): 2160.5.

https://doi.org/10.1182/blood.V110.11.2160.5.2160.5

Published: 2007

Journal Articles

AVE5026: A Novel, Extractive Heparinoid with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity.

Debra Hoppensteadt, PhD, Josephine Cunanan, M.D., Eric Geniaux, Ph.D., Martin Lorenz, Ph.D., Christian Viskov, Ph.D., Pascal Ythier-Moury, Ph.D., Jean-Francois Brin, M.D., Walter Jeske, Ph.D.

Blood (2007) 110 (11): 1881.

https://doi.org/10.1182/blood.V110.11.1881.1881

Published: 2007

Journal Articles

Defibrotide Does Not Cross-React with HIT Antibodies. Implications in the Management of HIT.

Jawed Fareed, PhD, Debra A. Hoppensteadt, PhD, Massimo Iacobelli, MD, Jeanine M. Walenga, PhD

Blood (2006) 108 (11): 1054.

https://doi.org/10.1182/blood.V108.11.1054.1054

Published: 2006

NARROW

Prothrombin Complex Concentrates (PCCs) Have Limited Effect on TF-Initiated Thrombin Generation in FXa Inhibitor-Anticoagulated Plasma: In Vitro Comparison between Direct Reversal By Andexanet Alfa and "Work Around" By PCCs

A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

A Novel Laboratory Assay for Monitoring Unfractionated Heparin in Patients Taking Direct Oral Anticoagulants Prior to Hospital Admission

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Rebound Hypercoagulability Following a Conventional Course of Anticoagulation and the Risk of Recurrent Venous Thromboembolism in Young Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid Syndrome

Multiple Myeloma Cells Adhere to Netrin-1 Via Heparin-Sulphate Moieties

Product Associated Variation in Generic Enoxaparin. Potential Clinical Implications

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Comparative Studies on An Anti-Xa Enriched Ultra Low Molecular Weight Heparin with Bemiparin

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Recombinant Factor VIIa Combined with Fibrinogen Corrects the Coagulopathy Associated with Cardiopulmonary Bypass Surgery Ex Vivo

Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.

Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.

Glycosaminoglycans as Anticoagulants in Mucopolysaccharidosis Type I (MPS I).

Glycosaminoglycans as Anticoagulants in Mucopolysaccharidosis Type I (MPS I).

AVE5026: A Novel, Extractive Heparinoid with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity.

Defibrotide Does Not Cross-React with HIT Antibodies. Implications in the Management of HIT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only